{"id":"https://openalex.org/W2115759907","doi":"https://doi.org/10.1586/17469899.2014.903801","title":"Adalimumab: viable treatment option for pediatric refractory uveitis?","display_name":"Adalimumab: viable treatment option for pediatric refractory uveitis?","publication_year":2014,"publication_date":"2014-03-31","ids":{"openalex":"https://openalex.org/W2115759907","doi":"https://doi.org/10.1586/17469899.2014.903801","mag":"2115759907"},"language":"en","primary_location":{"id":"doi:10.1586/17469899.2014.903801","doi":"https://doi.org/10.1586/17469899.2014.903801","is_oa":false,"landing_page_url":"https://doi.org/10.1586/17469899.2014.903801","pdf_url":null,"source":{"id":"https://openalex.org/S59055606","display_name":"Expert Review of Ophthalmology","issn_l":"1746-9899","issn":["1746-9899","1746-9902"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059837007","display_name":"Sumita Phatak","orcid":"https://orcid.org/0000-0002-5899-0882","observed_orcids":["https://orcid.org/0000-0002-5899-0882"]},"institutions":[{"id":"https://openalex.org/I1325675289","display_name":"Moorfields Eye Hospital NHS Foundation Trust","ror":"https://ror.org/03zaddr67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289"]},{"id":"https://openalex.org/I4210150574","display_name":"Moorfields Eye Hospital","ror":"https://ror.org/03tb37539","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sumita Phatak","raw_affiliation_strings":["Moorfields Eye Hospital, NHS Foundation Trust, City Road, London EC1V 2PD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moorfields Eye Hospital, NHS Foundation Trust, City Road, London EC1V 2PD, UK","institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052634452","display_name":"Rupesh V. Agrawal","orcid":"https://orcid.org/0000-0002-6662-5850","observed_orcids":["https://orcid.org/0000-0002-6662-5850"]},"institutions":[{"id":"https://openalex.org/I1325675289","display_name":"Moorfields Eye Hospital NHS Foundation Trust","ror":"https://ror.org/03zaddr67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289"]},{"id":"https://openalex.org/I2802408685","display_name":"Tan Tock Seng Hospital","ror":"https://ror.org/032d59j24","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2802408685"]},{"id":"https://openalex.org/I4210150574","display_name":"Moorfields Eye Hospital","ror":"https://ror.org/03tb37539","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]},{"id":"https://openalex.org/I4405257834","display_name":"National Healthcare Group","ror":"https://ror.org/05qkemg93","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4405257834"]}],"countries":["GB","SG"],"is_corresponding":false,"raw_author_name":"Rupesh Agrawal","raw_affiliation_strings":["Moorfields Eye Hospital, NHS Foundation Trust, City Road, London EC1V 2PD, UK; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore 308433, Singapore","Moorfields Eye Hospital, NHS Foundation Trust,\nCity Road, London EC1V 2PD, UK","National Healthcare Group Eye Institute, Tan Tock Seng Hospital,\nSingapore 308433, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moorfields Eye Hospital, NHS Foundation Trust, City Road, London EC1V 2PD, UK; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore 308433, Singapore","institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I2802408685","https://openalex.org/I4405257834"]},{"raw_affiliation_string":"Moorfields Eye Hospital, NHS Foundation Trust,\nCity Road, London EC1V 2PD, UK","institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]},{"raw_affiliation_string":"National Healthcare Group Eye Institute, Tan Tock Seng Hospital,\nSingapore 308433, Singapore","institution_ids":["https://openalex.org/I2802408685","https://openalex.org/I4405257834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012009183","display_name":"Carlos Eduardo Pavesio","orcid":"https://orcid.org/0000-0002-1625-2777","observed_orcids":["https://orcid.org/0000-0002-1625-2777"]},"institutions":[{"id":"https://openalex.org/I1325675289","display_name":"Moorfields Eye Hospital NHS Foundation Trust","ror":"https://ror.org/03zaddr67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289"]},{"id":"https://openalex.org/I4210150574","display_name":"Moorfields Eye Hospital","ror":"https://ror.org/03tb37539","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Carlos Pavesio","raw_affiliation_strings":["Moorfields Eye Hospital, NHS Foundation Trust, City Road, London EC1V 2PD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moorfields Eye Hospital, NHS Foundation Trust, City Road, London EC1V 2PD, UK","institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5012009183"],"corresponding_institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.24586054,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"9","issue":"3","first_page":"175","last_page":"184"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/pediatric-uveitis","display_name":"pediatric uveitis","score":0.8809999823570251},{"id":"https://openalex.org/keywords/refractory-uveitis","display_name":"refractory uveitis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.8759999871253967},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9769999980926514},{"id":"https://openalex.org/keywords/juvenile-idiopathic-arthritis","display_name":"juvenile idiopathic arthritis","score":0.7639999985694885},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.6549999713897705},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.6859999895095825},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4869999885559082},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4729999899864197},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.3019999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9698270559310913},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.9304152131080627},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8631597757339478},{"id":"https://openalex.org/C2776194053","wikidata":"https://www.wikidata.org/wiki/Q280027","display_name":"Uveitis","level":2,"score":0.8061645030975342},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6528170108795166},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5597570538520813},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.4860284924507141},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.43759816884994507},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4258570373058319},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3512013554573059},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3228278160095215},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.2685156464576721},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21169602870941162},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1586/17469899.2014.903801","doi":"https://doi.org/10.1586/17469899.2014.903801","is_oa":false,"landing_page_url":"https://doi.org/10.1586/17469899.2014.903801","pdf_url":null,"source":{"id":"https://openalex.org/S59055606","display_name":"Expert Review of Ophthalmology","issn_l":"1746-9899","issn":["1746-9899","1746-9902"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Ophthalmology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W1971437489","https://openalex.org/W1974793860","https://openalex.org/W1975459514","https://openalex.org/W1983004971","https://openalex.org/W1984188767","https://openalex.org/W1989940983","https://openalex.org/W1992051074","https://openalex.org/W1996117162","https://openalex.org/W1997106678","https://openalex.org/W2000771735","https://openalex.org/W2008468448","https://openalex.org/W2009068027","https://openalex.org/W2011782096","https://openalex.org/W2015131535","https://openalex.org/W2018600081","https://openalex.org/W2018720535","https://openalex.org/W2026718163","https://openalex.org/W2027446789","https://openalex.org/W2028254334","https://openalex.org/W2032008287","https://openalex.org/W2035451066","https://openalex.org/W2035856885","https://openalex.org/W2055081569","https://openalex.org/W2056930258","https://openalex.org/W2059101060","https://openalex.org/W2060549798","https://openalex.org/W2067601857","https://openalex.org/W2067821114","https://openalex.org/W2067874068","https://openalex.org/W2069806532","https://openalex.org/W2070932113","https://openalex.org/W2072898398","https://openalex.org/W2073247459","https://openalex.org/W2076365133","https://openalex.org/W2077199006","https://openalex.org/W2091721895","https://openalex.org/W2100413075","https://openalex.org/W2101168807","https://openalex.org/W2110511698","https://openalex.org/W2111615368","https://openalex.org/W2121081989","https://openalex.org/W2133321705","https://openalex.org/W2135325634","https://openalex.org/W2140539537","https://openalex.org/W2144337820","https://openalex.org/W2147214663","https://openalex.org/W2150944237","https://openalex.org/W2151238113","https://openalex.org/W2151557772","https://openalex.org/W2153221676","https://openalex.org/W2155934675","https://openalex.org/W2160597707","https://openalex.org/W2160986349","https://openalex.org/W2161886894","https://openalex.org/W2162870198","https://openalex.org/W2162947558","https://openalex.org/W2342269472","https://openalex.org/W2409408034","https://openalex.org/W2784941315"],"related_works":["https://openalex.org/W1981530488","https://openalex.org/W2140539537","https://openalex.org/W2133321705","https://openalex.org/W2160986349","https://openalex.org/W7052986095","https://openalex.org/W202878523","https://openalex.org/W1984188767","https://openalex.org/W2476550218","https://openalex.org/W1627279824","https://openalex.org/W2135325634"],"abstract_inverted_index":{"Non-infectious":[0],"childhood":[1,160],"uveitis,":[2],"with":[3,19,42,127],"its":[4,154,194],"chronic":[5],"nature,":[6],"has":[7,122,137,156],"the":[8,186],"potential":[9],"for":[10,38,74],"long-term":[11],"complications":[12],"and":[13,55,76,84,102,176,188,193],"possible":[14],"blindness.":[15],"Although":[16],"strongly":[17],"associated":[18,53],"an":[20],"underlying":[21],"autoimmune":[22],"systemic":[23,54],"disease":[24],"like":[25,130],"juvenile":[26],"idiopathic":[27],"arthritis,":[28],"a":[29,116,133,177],"significant":[30,81],"number":[31],"of":[32,119,144,180,191],"cases":[33,143],"are":[34],"idiopathic.":[35],"Treatment":[36],"protocols":[37],"pediatric":[39,198],"uveitis":[40],"start":[41],"steroids":[43],"as":[44,71,100,146,148],"their":[45,52,63],"safety":[46],"profile":[47],"is":[48],"well":[49,147],"known,":[50],"but":[51,78],"ocular":[56],"complications,":[57],"especially":[58],"in":[59,87,109,125,140,196],"children,":[60],"rule":[61],"out":[62],"long":[64],"-term":[65],"use.":[66],"Immunosuppressives":[67],"have":[68,80,93,105],"been":[69,94,123,157],"used":[70],"second":[72],"step":[73],"control":[75],"maintenance,":[77],"they":[79],"side":[82],"effects":[83],"limited":[85],"efficacy":[86,121],"recalcitrant":[88],"cases.":[89],"Therefore,":[90],"treatment":[91],"options":[92],"extended":[95,158],"to":[96,113,159],"TNF-\u03b1":[97],"inhibitors":[98],"such":[99],"infliximab":[101,168],"adalimumab":[103,192],"which":[104],"shown":[106,138],"good":[107],"success":[108],"patients":[110,126],"not":[111],"responding":[112],"immunosuppressives.":[114],"Significantly,":[115],"waning":[117],"off":[118],"clinical":[120,187],"observed":[124],"chimeric":[128],"biologics":[129],"infliximab.":[131],"Adalimumab,":[132],"fully":[134],"humanized":[135],"antibody,":[136],"promise":[139],"treating":[141],"refractory":[142,161,197],"systemic,":[145],"intraocular,":[149],"inflammation.":[150],"In":[151],"recent":[152],"years,":[153],"use":[155],"uveitis.":[162,199],"It":[163],"offers":[164],"several":[165],"advantages":[166],"over":[167],"including":[169],"easier":[170],"administration,":[171],"cost-effectiveness,":[172],"better":[173],"patient":[174],"compliance":[175],"lower":[178],"rate":[179],"adverse":[181],"events.":[182],"This":[183],"review":[184],"analyzes":[185],"pharmacological":[189],"features":[190],"role":[195]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}